Zimmer Biomet Holdings, INC Form 4 insider transactions

Kevin R Thornal, Grp Pres-Global Business of Zimmer Biomet Holdings, Inc., reported multiple transactions in common stock on August 1, 2026.

Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar reported the accrual of 180.323 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Robert Hagemann, a Director at Zimmer Biomet Holdings, Inc., has reported transactions related to phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Arthur J. Higgins, a Director at Zimmer Biomet Holdings, Inc., reported the acquisition of phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Director Sreelakshmi Kolli of Zimmer Biomet Holdings, Inc. has reported transactions related to phantom stock units, indicating changes in beneficial ownership.

Michael J. Farrell, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Zimmer Biomet Holdings, Inc. reports that Jehanzeb Noor, Senior Vice President, Chief Strategy, Innovation & Business Development Officer, acquired 1,857 Restricted Stock Units on June 1, 2026.

Zimmer Biomet Holdings, Inc. reports insider transactions involving the sale of common stock by Group President, Asia Pacific, Sang Yi.

Michael J. Farrell, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Betsy J. Bernard, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Maria Teresa Hilado, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Louis Shapiro, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Director Devdatt Kurdikar of Zimmer Biomet Holdings, Inc. reported transactions involving phantom stock units and restricted stock units.

Zimmer Biomet Holdings, Inc. Director Sreelakshmi Kolli has reported transactions involving phantom stock units and restricted stock units.

Syed A. Jafry, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Arthur J. Higgins, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Director Robert Hagemann of Zimmer Biomet Holdings, Inc. reported transactions involving phantom stock units and restricted stock units.

Paul A. Stellato, VP, Controller, CAO of Zimmer Biomet Holdings, Inc., was granted 9,232 Restricted Stock Units on May 1, 2026.

Zimmer Biomet Holdings, Inc. reports insider transactions, with Noor Jehanzeb acquiring shares and RSUs.

Director Syed A. Jafry acquired 182.421 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan.

Director Sreelakshmi Kolli acquired 175.404 phantom stock units under the company's deferred compensation plan.

Zimmer Biomet Holdings Director Louis Shapiro acquired 154.356 phantom stock units under the company's deferred compensation plan.

Director Maria Teresa Hilado acquired 378.873 phantom stock units under the company's deferred compensation plan.

Zimmer Biomet Holdings Director Arthur J. Higgins acquired 308.711 phantom stock units under the company's deferred compensation plan.

Director Devdatt Kurdikar acquired 154.356 phantom stock units under the Zimmer Biomet deferred compensation plan.

Director Robert Hagemann acquired 308.711 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan.

Director Michael J. Farrell acquired 420.97 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan.

Zimmer Biomet's SVP and CHRO, Lori Winkler, sold 2,650 shares of common stock for $94.66 per share under a pre-arranged trading plan.

Zimmer Biomet Holdings, Inc. Group President, EMEA, Wilfred van Zuilen, reported the vesting of restricted stock units and subsequent tax-related share withholding.